MX2015014904A - Reduccion del tamaño de particula de un compuesto antimuscarinico. - Google Patents
Reduccion del tamaño de particula de un compuesto antimuscarinico.Info
- Publication number
- MX2015014904A MX2015014904A MX2015014904A MX2015014904A MX2015014904A MX 2015014904 A MX2015014904 A MX 2015014904A MX 2015014904 A MX2015014904 A MX 2015014904A MX 2015014904 A MX2015014904 A MX 2015014904A MX 2015014904 A MX2015014904 A MX 2015014904A
- Authority
- MX
- Mexico
- Prior art keywords
- particle size
- size reduction
- drug
- antimuscarinic compound
- antimuscarinic
- Prior art date
Links
- 230000001022 anti-muscarinic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000010951 particle size reduction Methods 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 230000002776 aggregation Effects 0.000 abstract 2
- ANGKOCUUWGHLCE-HKUYNNGSSA-N [(3s)-1,1-dimethylpyrrolidin-1-ium-3-yl] (2r)-2-cyclopentyl-2-hydroxy-2-phenylacetate Chemical class C1[N+](C)(C)CC[C@@H]1OC(=O)[C@](O)(C=1C=CC=CC=1)C1CCCC1 ANGKOCUUWGHLCE-HKUYNNGSSA-N 0.000 abstract 1
- 238000005054 agglomeration Methods 0.000 abstract 1
- 238000004220 aggregation Methods 0.000 abstract 1
- 239000012296 anti-solvent Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 238000003860 storage Methods 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a un proceso para preparar a particulado cristalino micronizado de una sal de glicopirronio. El proceso incluye suspender al fármaco en un antisolvente inmiscible en agua, en el cual el fármaco tiene poca o ninguna solubilidad y micronizar la suspensión. Las partículas de fármaco que se obtienen como resultado son físicamente estables con respecto a la aglomeración y/o agregación durante el almacenamiento.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13165483 | 2013-04-26 | ||
PCT/EP2014/058295 WO2014173987A1 (en) | 2013-04-26 | 2014-04-24 | Particle size reduction of an antimuscarinic compound |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015014904A true MX2015014904A (es) | 2016-03-07 |
MX365295B MX365295B (es) | 2019-05-29 |
Family
ID=48190260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015014904A MX365295B (es) | 2013-04-26 | 2014-04-24 | Reduccion del tamaño de particula de un compuesto antimuscarinico. |
Country Status (28)
Country | Link |
---|---|
US (2) | US9393202B2 (es) |
EP (2) | EP2988728B1 (es) |
JP (1) | JP6449246B2 (es) |
KR (1) | KR102198354B1 (es) |
CN (1) | CN105120841B (es) |
AR (1) | AR096087A1 (es) |
AU (1) | AU2014259443B2 (es) |
BR (1) | BR112015024626B1 (es) |
CA (1) | CA2910314C (es) |
DK (2) | DK2988728T3 (es) |
ES (2) | ES2943109T3 (es) |
FI (1) | FI3574895T3 (es) |
HK (1) | HK1216302A1 (es) |
HR (2) | HRP20230337T1 (es) |
HU (2) | HUE062002T2 (es) |
IL (1) | IL242209A (es) |
MX (1) | MX365295B (es) |
MY (1) | MY169127A (es) |
PH (1) | PH12015502449A1 (es) |
PL (2) | PL2988728T3 (es) |
PT (2) | PT3574895T (es) |
RU (1) | RU2667636C2 (es) |
SG (1) | SG11201508760VA (es) |
SI (2) | SI3574895T1 (es) |
TW (1) | TWI630926B (es) |
UA (1) | UA120418C2 (es) |
WO (1) | WO2014173987A1 (es) |
ZA (1) | ZA201507916B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9393202B2 (en) * | 2013-04-26 | 2016-07-19 | Chiesi Farmaceutici S.P.A | Particle size reduction of an antimuscarinic compound |
SI3019153T1 (sl) | 2013-07-11 | 2018-12-31 | Chiesi Farmaceutici S.P.A. | Formulacija suhega praška, obsegajoča antiholinergik, kortikosteroid in beta-adrenergik, za dajanje z inhalacijo |
JP6653323B2 (ja) | 2014-10-16 | 2020-02-26 | テバ ブランデッド ファーマシューティカル プロダクツ アール アンド ディー インコーポレイテッド | 吸入可能な製剤 |
JP6500522B2 (ja) * | 2015-03-16 | 2019-04-17 | セイコーエプソン株式会社 | 回路装置、物理量検出装置、電子機器及び移動体 |
DK3689379T3 (da) | 2015-11-16 | 2021-09-06 | Chiesi Farm Spa | Fremgangsmåde til fremstilling af en tørpulverformulering omfattende et anticholinergikum, et corticosteroid og et beta-adrenergikum |
LT3377108T (lt) | 2015-11-16 | 2020-07-10 | Chiesi Farmaceutici S.P.A. | Inhaliacinių miltelių kompozicijos, apimančios anticholinerginį agentą, kortikosteroidą ir beta adrenerginį agentą, paruošimo būdas |
US9925168B2 (en) | 2016-01-22 | 2018-03-27 | Chiesi Farmaceutici S.P.A. | Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation |
JP6323846B2 (ja) * | 2016-04-07 | 2018-05-16 | 塩野義製薬株式会社 | オピオイドを含有する乱用防止製剤 |
PT109445B (pt) * | 2016-06-08 | 2018-11-06 | Hovione Farm Sa | Co-cristais farmacêuticos cristalinos de brometo de glicopirrónio com lactose |
PT3490533T (pt) * | 2016-07-29 | 2020-07-21 | Inke Sa | Processo de estabilização do tamanho de partícula |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399363A (en) * | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
DK0644755T3 (da) * | 1992-06-10 | 1997-09-22 | Nanosystems Llc | Overflademodificerede NSAID-nanopartikler |
GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
CN1713893A (zh) * | 2002-11-18 | 2005-12-28 | 纳幕尔杜邦公司 | 采用非球形研磨介质的介质研磨 |
GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
GB0409703D0 (en) * | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
GB0516549D0 (en) | 2005-08-12 | 2005-09-21 | Sulaiman Brian | Milling system |
GB0613161D0 (en) * | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
ES2460576T3 (es) * | 2007-12-13 | 2014-05-13 | Novartis Ag | Procedimiento para preparar una sustancia farmacológica en partículas y cristalina |
CN101896162B (zh) * | 2007-12-13 | 2013-06-05 | 诺瓦提斯公司 | 有机化合物 |
DE102008000482A1 (de) | 2008-03-03 | 2009-09-10 | Zf Friedrichshafen Ag | Ölgekühltes Reibschaltelement |
BRPI0915803A2 (pt) * | 2008-07-18 | 2015-11-10 | Prosonix Ltd | processo para aumentar a cristalinidade de pelo menos um material sólido, partícula, composição farmacêutica, e, inalador |
LT2435025T (lt) * | 2009-05-29 | 2016-09-26 | Pearl Therapeutics, Inc. | Veikliosios medžiagos tiekimas per kvėpavimo takus |
US20150093440A1 (en) * | 2010-10-15 | 2015-04-02 | Glaxo Group Limited | Aggregate nanoparticulate medicament formulations, manufacture and use thereof |
US9393202B2 (en) * | 2013-04-26 | 2016-07-19 | Chiesi Farmaceutici S.P.A | Particle size reduction of an antimuscarinic compound |
-
2014
- 2014-04-22 US US14/258,147 patent/US9393202B2/en active Active
- 2014-04-24 ES ES19182996T patent/ES2943109T3/es active Active
- 2014-04-24 MX MX2015014904A patent/MX365295B/es active IP Right Grant
- 2014-04-24 CN CN201480022369.0A patent/CN105120841B/zh active Active
- 2014-04-24 SI SI201432023T patent/SI3574895T1/sl unknown
- 2014-04-24 BR BR112015024626-5A patent/BR112015024626B1/pt active IP Right Grant
- 2014-04-24 TW TW103114823A patent/TWI630926B/zh active
- 2014-04-24 SI SI201431365T patent/SI2988728T1/sl unknown
- 2014-04-24 PT PT191829969T patent/PT3574895T/pt unknown
- 2014-04-24 HR HRP20230337TT patent/HRP20230337T1/hr unknown
- 2014-04-24 PL PL14724332T patent/PL2988728T3/pl unknown
- 2014-04-24 EP EP14724332.3A patent/EP2988728B1/en active Active
- 2014-04-24 WO PCT/EP2014/058295 patent/WO2014173987A1/en active Application Filing
- 2014-04-24 RU RU2015145521A patent/RU2667636C2/ru active
- 2014-04-24 HU HUE19182996A patent/HUE062002T2/hu unknown
- 2014-04-24 AR ARP140101710A patent/AR096087A1/es not_active Application Discontinuation
- 2014-04-24 CA CA2910314A patent/CA2910314C/en active Active
- 2014-04-24 AU AU2014259443A patent/AU2014259443B2/en active Active
- 2014-04-24 KR KR1020157026634A patent/KR102198354B1/ko active IP Right Grant
- 2014-04-24 EP EP19182996.9A patent/EP3574895B1/en active Active
- 2014-04-24 HU HUE14724332A patent/HUE046213T2/hu unknown
- 2014-04-24 PL PL19182996.9T patent/PL3574895T3/pl unknown
- 2014-04-24 JP JP2016509457A patent/JP6449246B2/ja active Active
- 2014-04-24 ES ES14724332T patent/ES2754255T3/es active Active
- 2014-04-24 UA UAA201510382A patent/UA120418C2/uk unknown
- 2014-04-24 SG SG11201508760VA patent/SG11201508760VA/en unknown
- 2014-04-24 FI FIEP19182996.9T patent/FI3574895T3/fi active
- 2014-04-24 MY MYPI2015002624A patent/MY169127A/en unknown
- 2014-04-24 DK DK14724332T patent/DK2988728T3/da active
- 2014-04-24 DK DK19182996.9T patent/DK3574895T3/da active
- 2014-04-24 PT PT147243323T patent/PT2988728T/pt unknown
-
2015
- 2015-10-22 IL IL242209A patent/IL242209A/en active IP Right Grant
- 2015-10-23 PH PH12015502449A patent/PH12015502449A1/en unknown
- 2015-10-23 ZA ZA2015/07916A patent/ZA201507916B/en unknown
-
2016
- 2016-06-08 HK HK16104300.9A patent/HK1216302A1/zh unknown
- 2016-06-10 US US15/179,048 patent/US9889094B2/en active Active
-
2019
- 2019-10-17 HR HRP20191882TT patent/HRP20191882T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015502449A1 (en) | Particle size reduction of an antimuscarinic compound | |
HK1211579A1 (en) | Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl- cyano-methyl)-amides inhibitors of athepsin 2--[221]-3-(--)- | |
HK1216173A1 (zh) | -芳基取代的和 -雜芳基取代的 -羥基吡啶- -基-羰基氨基-鏈烷酸及其衍生物和其鹽,以及用相應 -羥基吡啶甲酸的衍生物進行製備的方法 | |
HK1212616A1 (zh) | 多孔載體顆粒和微粒化藥物的可吸入團聚物 | |
HRP20221047T1 (hr) | Derivat kinolina visoke čistoće i postupak za njegovu proizvodnju | |
EA201590161A1 (ru) | Составы этанерцепта, отличающиеся заметным уменьшением содержания частиц довидимого диапазона | |
WO2013132457A3 (en) | Nanocrystalline solid dispersion compositions and process of preparation thereof | |
PH12016500814B1 (en) | Heteroaryl butanoic acid derivatives | |
SI2612851T1 (sl) | Postopek za pripravo L-argininske soli perindoprila | |
HK1220444A1 (zh) | 拉喹莫德鈉晶體和用於製造它們的改進方法 | |
GB201813024D0 (en) | System and methods for aggregation of cloud storage | |
EP2964032A4 (en) | COMPOSITIONS AND METHOD FOR THE PRODUCTION OF VIRUSELIC PARTICLES | |
HK1187061A1 (en) | Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it | |
MX2015016958A (es) | Sintesis de dicarbamatos de isohexida y derivados de estos. | |
GB201322840D0 (en) | Aqueous suspension of inorganic particulate material | |
PL3083557T3 (pl) | Sposób otrzymywania 3-podstawionych estrów kwasu (indol-1-ilo)-octowego | |
MX2018013764A (es) | Cristal de derivado de quinolina. | |
HK1205449A1 (en) | Package for solid preparation including 5-hydroxy-1h-imidazole-4- carboxamide or salt or hydrate thereof 5--1h--4- | |
PT3066076T (pt) | Processo de preparação de metilfenidato de metilo e dos respetivos sais farmacêuticos | |
MX2018008824A (es) | Preparacion de particulas micronizadas de un compuesto antimuscarinico por cavitacion hidrodinamica. | |
TH163807A (th) | การลดขนาดอนุภาคของสารประกอบต้านมัสคารีน | |
TH163807B (th) | การลดขนาดอนุภาคของสารประกอบต้านมัสคารีน | |
IN2014MU00328A (es) | ||
GR1007770B (el) | Φαρμακευτικο σκευασμα περιεχον ρεπαγλινιδη και μεθοδος για την παρασκευη αυτου | |
RU2014144841A (ru) | Способ эндотелиопротекции наноструктурированным L-аргинином |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |